Daily BriefsEquity Bottom-Up

Daily Brief Equity Bottom-Up: Playmates Toys: Mario Bros Movie Surpasses $1.3 Billion in Box Office; TMNT Next? and more

In today’s briefing:

  • Playmates Toys: Mario Bros Movie Surpasses $1.3 Billion in Box Office; TMNT Next?
  • LINK REIT – the Largest REIT in Asia, Firmly on a Post-Covid Recovery with Attractive Valuation
  • Smartkarma Corporate Webinar | UMP Healthcare: An Undervalued Gem in Hong Kong’s Healthcare Market
  • Secom (9735) | Share Price Surge Expected as Activist Proposals Gain Attention
  • $GSIT. Meme Stock Or NVIDIA Slayer?
  • RPSGV: Record Views of IPL Bodes Well for the Sports Business
  • Recruit Holdings: Recent Rally in Share Price Is Unwarranted
  • Light and Wonder Targets Asia for Growth After Divesting Two Verticals, Buying Social Gaming Unit
  • NIO Inc. (NIO US, BUY, TP US$10.5) Rating Change: Witnessing a Turning Point…UG to BUY
  • Carta Holdings (3688 JP) – 1Q FOLLOW-UP


Playmates Toys: Mario Bros Movie Surpasses $1.3 Billion in Box Office; TMNT Next?

By Nicolas Van Broekhoven

  • 1983 was the year both TMNT and Mario Bros were created by two different animation studios
  • Mario Bros latest movie has now grossed $1.3 billion in box office receipts YTD, entering the all-time top-3 of animated movies 
  • TNMT will see its debut in US theatres on the 2nd of August 2023. Will the turtles get the same reception as Mario Bros?

LINK REIT – the Largest REIT in Asia, Firmly on a Post-Covid Recovery with Attractive Valuation

By Jacob Cheng

  • We conducted fundamental analysis on Link REIT, the largest REIT In Asia, who owns and operates retail assets, office buildings and logistics in the APAC region
  • Link REIT has strong track record for capital management, we expect that to continue.  In the LT, Link REIT is on the path to grow its fund management business
  • Link REIT is currently trading at 0.64x P/B and 6% dividend yield, which is attractive from a historical perspective

Smartkarma Corporate Webinar | UMP Healthcare: An Undervalued Gem in Hong Kong’s Healthcare Market

By Smartkarma Research

For our next Corporate Webinar, we are glad to welcome UMP Healthcare’s  Chief Investment & Project Officer, Patrick Cheung. 

In the upcoming webinar, Patrick will share a short company presentation after which, he will engage in a fireside chat with Smartkarma Insight Provider, Sameer Taneja. The Corporate Webinar will include a live Q&A session.

The webinar will be hosted on Monday, 19 June 2023, 17:00 SGT/HKT.

About UMP Healthcare

Founded in 1990, UMP Healthcare is a medical group listed on the main board of the Hong Kong Stock Exchange (stock code 722.HK) and is one of the leading comprehensive healthcare service platforms in the Hong Kong market. We have been committed “To provide comprehensive, diversified and coordinated care for everyone” by creating a network of high-quality and effective medical services for patients, payers, providers and partners.

Along with providing healthcare services that address a wide range of individual needs, UMP closely works with more than 2,000 local and international businesses and insurance organizations to establish and administer corporate healthcare benefit programs for members. The medical service network spans over 1,000 self-owned and affiliated institutions across Hong Kong, Macau, and Mainland China, offering services such as family medicine, specialist consultation, dental care, diagnostic imaging and laboratory testing, preventive medicine and health examination, physical therapy, day surgery, and endoscopy, among others. In 2022, the annual volume of outpatient visits under UMP exceeded 1.1 million.


Secom (9735) | Share Price Surge Expected as Activist Proposals Gain Attention

By Mark Chadwick

  • Secom’s share price has surged by 8% following shareholder proposals submitted by Dalton Investments, raising expectations for potential approval of a 10% share buyback and its impact on stock price.
  • Secom, operating in a mature industry with limited growth prospects, faces challenges in deploying capital and maintaining consistent earnings growth, leading to an accumulation of capital on its balance sheet.
  • While Dalton’s proposals may not gain sufficient support to pass at the upcoming AGM, the potential involvement of other activists warrant a bullish outlook.

$GSIT. Meme Stock Or NVIDIA Slayer?

By William Keating

  • GSI Technology (GSIT US) share price is up ~5x in the past month fuelled by the fact that they have an AI Accelerator (APU) called Gemini-I
  • Launched in 2020, Gemini-I was 3 years late, has never been properly benchmarked and has thus far attracted just one customer, the Israeli military
  • We remain wholly unconvinced that GSIT is on the cusp of a breakthrough in the world of Accelerated AI

RPSGV: Record Views of IPL Bodes Well for the Sports Business

By Ankit Agrawal, CFA

  • IPL 2023 concluded recently with record streaming views and TV viewership. This bodes well for the valuation of the IPL Lucknow franchise owned by RPSG Ventures Limited (RPSGVENT IN) [“RPSGV”]. 
  • FMCG business is currently doing a run-rate of INR 400cr+ revenue, however, needs to scale up faster. To drive this, Too Yumm! has entered into a new category, traditional Namkeens.
  • The Firstsource Solutions business seems to be bottoming out. Operating margin has stabilized in the 11.5-12% range. FY23 revenues de-grew at -1.1% YoY as guided at -1% to -2%.

Recruit Holdings: Recent Rally in Share Price Is Unwarranted

By Shifara Samsudeen, ACMA, CGMA

  • Recruit’s share price been up +13% YTD and gained more than 22% over the last 30-days with the US Dept of Labour releasing job data for April 2023.
  • Job openings were 10.1m in April 2023 vs estimates of c. 9.4m which created positive sentiment over labour market’s resilience to economic turmoil. However, April numbers were 13.5% down YoY.
  • Recruit Holdings (6098 JP) is currently trading at a lofty FY+2 EV/EBIT multiple of 17.9x despite earnings expectations deteriorating, we are set to benefit nicely on the short side.

Light and Wonder Targets Asia for Growth After Divesting Two Verticals, Buying Social Gaming Unit

By Howard J Klein

  • 2022 saw Light and Wonder make a major strategic pivot from legacy units to focus on three core businesses: Gaming equipment and systems, social online gaming and IGaming.
  • Recent move to acquire the 17% of SciPlay social gaming platform it does not own has evoked investor interest in the sector due to a 29% premium on offer.
  • After taking a big tax hit related to the sale of two of its legacy verticals the company is well positioned to compete for rising Asia-Pacific gaming equipment business.

NIO Inc. (NIO US, BUY, TP US$10.5) Rating Change: Witnessing a Turning Point…UG to BUY

By Shawn Yang

  • We think by adopting the new strategy to unbind vehicle sales with battery swapping, NIO could broaden its customer base to non-Yangtze-Delta regions and regain price competitiveness.
  • We upgrade to BUY and raise TP to US$ 10.5, due to 1) recovered growth outlook brought by widened customer base, more competitive pricing and intact model cycle
  • And 2) smaller-than-feared margin pressure. Our TP implies 2x PS. 

Carta Holdings (3688 JP) – 1Q FOLLOW-UP

By Sessa Investment Research

  • In 1Q FY23/12, CARTA Holdings posted a 23.3% YoY increase in transaction volume for programmatic TV commercial service TELECY, and a 2.8-fold increase in gross sales in the retail domain, showing steady performance in the mass retail domain, which the company has positioned as a priority area in its medium-term management plan.
  • On the other hand, the weak macro environment continued to weigh on double-digit sales declines in reservation-based ads, resulting in a 7.7% YoY drop in sales and a 59.3% drop in operating profit overall. 
  • YoY comparisons will ease off from the next quarter, but with 2Q usually being a slow period for advertising and the lack of activity from advertisers in the new fiscal year from April onward, earnings are expected to recovery smoothly rather than sharply.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars